SCHEMBL9900012

SCHEMBL9900012

O=C(Nc1ccccc1-c1ccc(OS(=O)(=O)C(F)(F)F)cc1)OCCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 14/20 0.48
MGLL Q99685 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
ROCK2 O75116 1/20 0.43
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41
NPC1 O15118 1/20 0.41
RECQL P46063 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTPN1 P18031 1/20 0.39
ALDH1A1 P00352 1/20 0.39
NPY1R P25929 1/20 0.39
NPY2R P49146 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9899613 0.88 ROCK2 (0.43) CHRM3MGLLROCK2NPC1RECQL
SCHEMBL9899749 0.77 SLC22A12 (0.42) CHRM3
SCHEMBL15261885 0.76 LPAR1 (0.45) CHRM3CA12CA1CA2CA9
SCHEMBL9915920 0.76 LPAR1 (0.45) CHRM3CA12CA1CA2CA9
SCHEMBL9905623 0.74 MGLL (0.50) CHRM3MGLLROCK2CHRM2CHRM1
SCHEMBL16926998 0.71 CA1 (0.47) CA12CA1CA2CA9CHRM1
SCHEMBL6609768 0.70 CYP1A2 (0.63) CHRM3CHRM2CHRM1SMN1; SMN2ALDH1A1
SCHEMBL10875637 0.69 MGLL (0.55) MGLLROCK2NPC1RECQLRAB9A
SCHEMBL17856291 0.69 CHRM3 (0.59) CHRM3CHRM2CHRM1ALDH1A1NPY1R
SCHEMBL5368850 0.69 PLAU (0.61) MGLLNPC1RAB9APTPN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2648714-A2 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND USES THEREOF Amira Pharmaceuticals, Inc. (US) 2013-10-16 EP disclosed
WO-2012078593-A2 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND USES THEREOF AMIRA PHARMACEUTICALS, INC. (US) 2012-06-14 WO disclosed